RARA and neoplasm: First, it has been demonstrated that RARα was overexpressed in human esophageal carcinoma, whereas silencing RARα expression can attenuate ESCC tumor cell proliferation and metastatic ability through suppressing the Wnt/β-catenin mechanism to resensitize ESCC to chemotherapy treatment [12].